United States · FDA National Drug Code directory
LORATADINE
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 51316-502_28e49606-cbf6-7029-e063-6394a90ae3b7
- Product NDC
- 51316-502
- Form
- TABLET, ORALLY DISINTEGRATING
- Composition / generic term
- LORATADINE
- Labeler
- CVS PHARMACY, INC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20211231
- Source listing expiry
- 20261231
Source-listed ingredients
- LORATADINE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BLISTER PACK in 1 CARTON (51316-502-01) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 51316-502-01
- 2 BLISTER PACK in 1 CARTON (51316-502-02) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 51316-502-02
- 3 BLISTER PACK in 1 CARTON (51316-502-03) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 51316-502-03
- 4 BLISTER PACK in 1 CARTON (51316-502-04) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 51316-502-04
- 5 BLISTER PACK in 1 CARTON (51316-502-05) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 51316-502-05
- 6 BLISTER PACK in 1 CARTON (51316-502-06) / 10 TABLET, ORALLY DISINTEGRATING in 1 BLISTER PACK · 51316-502-06
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →